366 related articles for article (PubMed ID: 18390638)
1. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm.
de Bruin DM; Burnes DL; Loewenstein J; Chen Y; Chang S; Chen TC; Esmaili DD; de Boer JF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4545-52. PubMed ID: 18390638
[TBL] [Abstract][Full Text] [Related]
2. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab.
Sayanagi K; Sharma S; Yamamoto T; Kaiser PK
Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732
[TBL] [Abstract][Full Text] [Related]
3. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
4. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
Khurana RN; Dupas B; Bressler NM
Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
[TBL] [Abstract][Full Text] [Related]
5. Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography.
Framme C; Panagakis G; Birngruber R
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1671-6. PubMed ID: 19875667
[TBL] [Abstract][Full Text] [Related]
6. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.
Malamos P; Sacu S; Georgopoulos M; Kiss C; Pruente C; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4926-33. PubMed ID: 19494200
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration.
Coscas F; Coscas G; Souied E; Tick S; Soubrane G
Am J Ophthalmol; 2007 Oct; 144(4):592-9. PubMed ID: 17698019
[TBL] [Abstract][Full Text] [Related]
8. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
Keane PA; Chang KT; Liakopoulos S; Jivrajka RV; Walsh AC; Sadda SR
Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
[TBL] [Abstract][Full Text] [Related]
9. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease.
Ahlers C; Golbaz I; Einwallner E; Dunavölgyi R; Malamos P; Stock G; Pruente C; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3417-24. PubMed ID: 19168899
[TBL] [Abstract][Full Text] [Related]
10. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.
Sayanagi K; Sharma S; Kaiser PK
Br J Ophthalmol; 2009 May; 93(5):622-6. PubMed ID: 19208677
[TBL] [Abstract][Full Text] [Related]
11. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography.
Yasuno Y; Miura M; Kawana K; Makita S; Sato M; Okamoto F; Yamanari M; Iwasaki T; Yatagai T; Oshika T
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):405-13. PubMed ID: 18676629
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
You JY; Chung H; Kim HC
Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
[TBL] [Abstract][Full Text] [Related]
13. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
14. Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography.
Ahlers C; Simader C; Geitzenauer W; Stock G; Stetson P; Dastmalchi S; Schmidt-Erfurth U
Br J Ophthalmol; 2008 Feb; 92(2):197-203. PubMed ID: 17965102
[TBL] [Abstract][Full Text] [Related]
15. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study.
Do DV; Gower EW; Cassard SD; Boyer D; Bressler NM; Bressler SB; Heier JS; Jefferys JL; Singerman LJ; Solomon SD
Ophthalmology; 2012 Apr; 119(4):771-8. PubMed ID: 22297028
[TBL] [Abstract][Full Text] [Related]
16. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
[TBL] [Abstract][Full Text] [Related]
17. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies.
Stopa M; Bower BA; Davies E; Izatt JA; Toth CA
Retina; 2008 Feb; 28(2):298-308. PubMed ID: 18301035
[TBL] [Abstract][Full Text] [Related]
19. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
Ahlers C; Golbaz I; Stock G; Fous A; Kolar S; Pruente C; Schmidt-Erfurth U
Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694
[TBL] [Abstract][Full Text] [Related]
20. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
Carvounis PE; Kopel AC; Benz MS
Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
